189 related articles for article (PubMed ID: 23627410)
1. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study.
Dossus L; Jimenez-Corona A; Romieu I; Boutron-Ruault MC; Boutten A; Dupré T; Fagherazzi G; Clavel-Chapelon F; Mesrine S
Cancer Causes Control; 2014 Apr; 25(4):533-9. PubMed ID: 24504436
[TBL] [Abstract][Full Text] [Related]
4. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea.
Kim Y; Park SK; Han W; Kim DH; Hong YC; Ha EH; Ahn SH; Noh DY; Kang D; Yoo KY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
7. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.
Onitilo AA; Engel JM; Stankowski RV; Liang H; Berg RL; Doi SA
Breast Cancer Res Treat; 2012 Jul; 134(1):291-8. PubMed ID: 22476854
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
11. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
12. The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes.
Liu ZM; Ho SC
Maturitas; 2011 Oct; 70(2):176-81. PubMed ID: 21821372
[TBL] [Abstract][Full Text] [Related]
13. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and biological characteristics of breast cancers in postmenopausal women.
Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
[TBL] [Abstract][Full Text] [Related]
18. Energy balance and breast cancer risk: a prospective cohort study.
Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
[TBL] [Abstract][Full Text] [Related]
19. Adipocytokine resistin and breast cancer risk.
Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
[TBL] [Abstract][Full Text] [Related]
20. Serum sex hormone levels in pre- and postmenopausal breast cancer patients.
Ho CC; Rohaizak M; Zulkifli SZ; Siti-Aishah MA; Nor-Aini U; Sharifah-Noor-Akmal SH
Singapore Med J; 2009 May; 50(5):513-8. PubMed ID: 19495523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
